Sodium Oxybate 11014-0487-02
- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- For Suspension, Extended Release
- Product Type
- Drug For Further Processing
- DEA Schedule
- Schedule CIII
- Marketing Start
- October 9, 2023
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Sodium Oxybate | 7.5 g/1 |
Selected Package
11014-0487-02Selected1 PACKET in 1 DRUM (11014-0487-2) / 1700 FOR SUSPENSION, EXTENDED RELEASE in 1 PACKET